Failure of glucagon in the treatment of alcoholic pancreatitis.
Glucagon has been claimed to be an effective treatment for pancreatitis, but the studies reporting this were either uncontrolled or did not use concurrent controls, and none were double blind. To evaluate the efficacy of glucagon for alcohol-related pancreatitis, we performed a controlled, randomized, double blind study. Twenty-six patients with pancreatitis associated with alcohol ingestion received either glucagon or placebo in addition to intravenous fluids, nasogastric suction, and meperidine as needed. There were no statistically significant differences between the group which received glucagon and the group which did not in any of 12 parameters which included symptoms, signs, laboratory tests, and requests for analgesia. We conclude that glucagon in addition to conventional therapy is no better for the treatment of alcoholic pancreatitis than conventional therapy alone.
D000437:Alcoholism / Q000150:complications; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005934:Glucagon / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy* / Q000209:etiology
D005934:Glucagon; D008614:Meperidine